BioWorld MedTech

Sep. 11, 2015

Funding Breast Imaging Technology: Delphinus raises $39.5M to fuel SoftVue commercialization efforts

A company developing an imaging system for breast cancer screening is getting noticed in the venture capital community. Delphinus Medical Technologies (Plymouth Township, Mich.) has raised $39.5 million in a Series C financing round. Read More

Inside the Beltway: MedPAC backs Linac utilization rate of 70% seen in MPFS draft

Epic going Dutch: Epic Systems goes global with the launch of Dutch electronic medical records

Second Feasibility study Underway: Lumicell receives FDA nod for GI cancer imaging feasibility study

Agreements/contracts: IBM opens Watson Health center with new partners

Buyout on the Mind: Mindray lowers privatization bid to $3.2 billion citing weak financials

Patents: VolitionRx receives patent for epigenetic blood test

HIT Bits: AccentHealth launches digital patient engagement platform

Briefly noted

People in Places

Products

MDD's Diagnostics Extra

Today's news in brief

BioWorld

BioWorld briefs for May 21, 2026.

Acid alpha-glucosidase molecular structure isolated on black

‘Detargeted’ targeted gene therapy improves activity in Pompe

BioWorld

A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...

News in brief

BioWorld Asia

BioWorld Asia briefs for May 19, 2026

WHO declares Ebola outbreak a public health emergency of international concern

BioWorld

The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...

Nxera Pharma prepares and tests new GPR17 antagonists

BioWorld Science

Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...